Quarterly Results

  • Company Name :
Glenmark Pharmaceuticals Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 532296
  • NSE Symbol:
  • GLENMARK
  • P/E(TTM):
  • 40.66
  • ISIN Demat:
  • INE935A01035
  • Div & Yield%:
  • 0.12
  • EPS(TTM):
  • 52.57
  • Book Value(₹):
  • 848.31
  • Market Cap(₹Cr.):
  • 60,326.07
  • Face Value(₹):
  • 1.00
Quarters :  
Particulars December 2025 ( Cr)September 2025 ( Cr)June 2025 ( Cr)
Gross Sales 2,328.23 1,219.53 2,178.90
Excise Duty 0.00 0.00 0.00
Net Sales 2,328.23 1,219.53 2,178.90
Other Operating Income 31.70 319.13 216.03
Other Income 109.06 285.76 69.34
Total Income 2,468.99 1,824.42 2,464.26
Total Expenditure 2,041.30 2,648.45 1,990.00
PBIDT 427.69 -824.04 474.26
Interest 21.98 23.40 15.46
PBDT 405.71 -847.43 458.80
Depreciation 59.18 58.93 57.64
Tax 0.00 -70.17 70.17
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 64.46 -97.01 0.77
Reported Profit After Tax 282.07 -739.19 330.23
Extra-ordinary Items -144.13 -931.79 -266.07
Adjusted Profit After Extra-ordinary item 426.20 192.60 596.30
EPS (Unit Curr.) 10.00 -26.19 11.70
EPS (Adj) (Unit Curr.) 10.00 -26.19 11.70
Calculated EPS (Unit Curr.) 10.00 -26.19 11.70
Calculated EPS (Adj) (Unit Curr.) 10.00 -26.19 11.70
Calculated EPS (Ann.) (Unit Curr.) 39.98 -104.78 46.81
Calculated EPS (Adj) (Ann.) (Unit Curr.) 39.98 -104.78 46.81
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 28.22 28.22 28.22
Reserve & Surplus 0.00 0.00 0.00
Face Value 1.00 1.00 1.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 18.37 -67.57 21.77
PBDTM(%) 17.43 -69.49 21.06
PATM(%) 12.12 -60.61 15.16